FDA approval of Wegovy in pill form The U.S
Melphalan transport, glutathione levels, and glutathione-S-transferase activity in research-subject medulloblastoma
(Well, sort of.) On Wednesday, when the $588 billion company debuted its powerful new weight loss drug, Zepbound, it did something unusual in the pharmaceutical world: It undercut the competition, pricing the shot almost 20% lower than Novo Nordisk's Wegovy
Monitoring thyroid safety with GLP-1 agonists provides reassurance
A pooled analysis of CVOTs showing that therapy with GLP-1 RA does not increase the risk of acute pancreatitis or pancreatic cancer
Always compare in milligrams, and always verify concentration before assuming anything about dose equivalence